GlassScriptPhysician profile
Anthony A Emmer
NPI 1003819897
$173,169.74
in general payments reported to CMS, 2019-2025
92 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $16K · 2021: $35K · 2022: $54K · 2023: $27K · 2024: $12K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Consulting Fee: $15K · Education: $186 · Travel and Lodging: $34.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21,805.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,837.50 |
| Consulting Fee | $15,361.00 |
| Education | $185.50 |
| Travel and Lodging | $34.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $54,804.60 | 2019-2025 | |
| Impel Pharmaceuticals INC. | $34,758.95 | 2022-2023 | Trudhesa |
| Allergan, INC. | $16,504.76 | 2019-2021 | |
| Genzyme Corporation | $15,704.85 | 2019-2025 | |
| Pfizer INC. | $8,689.14 | 2021-2025 | |
| Emd Serono, INC. | $4,755.62 | 2019-2025 | Mavenclad, Mavenclad |
| Novartis Pharmaceuticals Corporation | $3,581.17 | 2019-2025 | |
| Biogen, INC. | $3,414.39 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Ucb, INC. | $2,634.42 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $2,278.17 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Catalyst Pharmaceuticals, INC. | $1,768.96 | 2020-2025 | |
| Lilly USA, LLC | $1,366.83 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Neurocrine Biosciences, INC. | $1,110.99 | 2019-2025 | Ingrezza, Ongentys |
| Amgen INC. | $1,096.68 | 2019-2025 | Uplizna, Aimovig |
| Celgene Corporation | $1,041.00 | 2020-2025 | Zeposia |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Banner Life Sciences, LLC | $1,032.60 | 2021-2022 | |
| Tg Therapeutics, INC. | $933.21 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $889.25 | 2019-2025 | Ultomiris, Soliris |
| Genentech USA, INC. | $795.36 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Alnylam Pharmaceuticals INC. | $768.53 | 2019-2025 | Onpattro, Amvuttra |
| Lundbeck LLC | $686.27 | 2019-2025 | Vyepti, Rexulti |
| Eisai INC. | $650.17 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $646.45 | 2020-2023 | |
| Argenx US, INC. | $629.31 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $596.13 | 2019-2025 | Nuplazid |
| Avanir Pharmaceuticals, INC. | $573.97 | 2019-2022 | |
| Acorda Therapeutics, INC | $564.09 | 2019-2024 | Inbrija |
| Sk Life Science, INC. | $557.34 | 2020-2025 | |
| Neurelis, INC. | $551.54 | 2021-2025 | Valtoco |
| Astrazeneca Pharmaceuticals LP | $534.39 | 2021-2025 | Wainua, Andexxa, Evusheld |
| Kyowa Kirin, INC. | $516.16 | 2020-2024 | Nourianz |
| Scilex Pharmaceuticals INC. | $505.00 | 2019-2024 | Ztlido |
| Takeda Pharmaceuticals U.S.A., INC. | $420.84 | 2022-2025 | Hyqvia, Gammagard |
| Jazz Pharmaceuticals INC. | $382.36 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $349.18 | 2023-2024 | Aptiom |
| Csl Behring | $338.84 | 2019-2025 | Hizentra |
| Mdd US Operations, LLC | $332.23 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $323.41 | 2022-2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $322.91 | 2020-2024 | Zeposia |
| Sunovion Pharmaceuticals INC. | $306.45 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $299.94 | 2020-2023 | |
| Vanda Pharmaceuticals INC. | $295.67 | 2020-2025 | Ponvory |
| Horizon Therapeutics Plc | $294.06 | 2021-2023 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $292.70 | 2021 | |
| Amneal Pharmaceuticals LLC | $280.83 | 2019-2025 | Crexont, Rytary, Brekiya |
| Axsome Therapeutics, INC. | $253.36 | 2024-2025 | Symbravo, Sunosi, Auvelity |
| Otsuka America Pharmaceutical, INC. | $247.20 | 2023-2025 | Rexulti, Nuedexta |
| Supernus Pharmaceuticals, INC. | $212.37 | 2019-2022 | |
| Corium, LLC | $211.82 | 2022-2023 | Adlarity |
| Biohaven Pharmaceutical Holding Company LTD. | $198.75 | 2022 | |
| Adamas Pharmaceuticals, INC. | $186.64 | 2019-2021 | |
| Harmony Biosciences LLC | $169.55 | 2020-2025 | |
| Grifols USA, LLC | $160.38 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $159.52 | 2020-2025 | Acthar |
| Tanabe Pharma America, INC. | $157.12 | 2019-2025 | Radicava |
| Validus Pharmaceuticals LLC | $128.47 | 2019-2023 | Equetro |
| Cycle Pharmaceuticals INC | $126.39 | 2024-2025 | Tascenso Odt, Bafiertam, Ormalvi |
| Octapharma USA, INC. | $120.52 | 2023-2025 | Panzyga |
| Sanofi-Aventis U.S. LLC | $112.12 | 2019-2020 | |
| Akcea Therapeutics, INC. | $99.33 | 2019-2021 | |
| Greenwich Biosciences, INC. | $99.10 | 2019-2020 | |
| Aquestive Therapeutics, INC. | $94.69 | 2019-2022 | |
| Cala Health, INC. | $93.05 | 2022-2023 | Cala Trio, Cala Kiq |
| Merz Pharmaceuticals, LLC | $87.24 | 2024-2025 | Inbrija, Xeomin, Ampyra |
| Bausch Health US, LLC | $86.97 | 2019 | |
| Livanova USA, INC. | $69.14 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Hospira, INC. | $68.61 | 2024-2025 | |
| Mallinckrodt Enterprises LLC | $60.53 | 2019 | |
| Almatica Pharma LLC | $60.31 | 2020 | |
| Aucta Pharmaceuticals, INC. | $57.30 | 2025 | Motpoly Xr |
| Promius Pharma LLC | $55.05 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $54.51 | 2024-2025 | Lumryz |
| Currax Pharmaceuticals LLC | $48.91 | 2020-2021 | |
| Assertio Therapeutics, INC. | $48.44 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $48.36 | 2023 | Quviviq |
| Azurity Pharmaceuticals, INC. | $44.33 | 2023-2024 | Horizant, Horizant |
| Avion Pharmaceuticals | $40.69 | 2022 | |
| Ge Healthcare | $35.16 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $34.30 | 2020-2021 | |
| Globus Medical, INC. | $31.74 | 2025 | Senza |
| Zyla Life Sciences, INC. | $27.96 | 2020 | |
| Averitas Pharma INC. | $26.49 | 2024 | Qutenza |
| Xeris Pharmaceuticals, INC. | $25.10 | 2025 | Keveyis |
| Genentech, INC. | $22.01 | 2019 | |
| Arbor Pharmaceuticals, INC. | $21.61 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.55 | 2024 | Rexulti |
| Abbott Laboratories | $17.90 | 2025 | Infinity |
| Collegium Pharmaceutical, INC. | $14.92 | 2022 | |
| Neuronetics, INC. | $14.65 | 2025 | Neurostar Tms Therapy System |
| Zogenix INC. | $12.60 | 2021 | |
| Alfasigma USA, INC. | $12.13 | 2022 | |
| Biodelivery Sciences International, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
Trudhesa $13KUbrelvy $11KNurtec Odt $8,592Qulipta $8,443Kesimpta $1,462Briumvi $901Mavenclad $784Briviact $642Ingrezza $635Tysabri $622Zeposia $600Botox $559Nuplazid $475Austedo Xr $470Nayzilam $447Wainua $442Valtoco $430Ultomiris $426Onpattro $402Zavzpret $375Vyepti $374Rystiggo $361Aptiom $349Rexulti $347Uplizna $318Vumerity $315Epidiolex $312Ocrevus $306Vyvgart $303Leqembi $300Ajovy $270Vyvgart Hytrulo $248Kisunla $242Purified Cortrophin Gel $231Hyqvia $212Panzyga $211Ocrevus Zunovo $204Duopa $202Adlarity $196Hizentra $191Inbrija $184Ongentys $180Ponvory $180Enspryng $179Ztlido $159Wakix $156Avonex $155Nourianz $135Amyvid $132Amvuttra $128Symbravo $128Fintepla $121Vraylar $121Tascenso Odt $111Radicava $103Sunosi $102Emgality $99.50Reyvow $99.50Aubagio $98.87Andexxa $93.23Octagam Immune Globulin (Human) $90.00Gammagard $89.71Crexont $87.75Nuedexta $79.79Radicava Ors $71.37Skyclarys $70.42Comirnaty $67.50Bafiertam $64.40Acthar $63.45Fycompa $62.26Xeomin $62.05Vyalev $60.04Motpoly Xr $57.30Austedo $54.84Lumryz $54.51Vns Therapy Sentiva Model 1000 Generator $54.28Cala Trio $52.71Equetro $49.25Quviviq $48.36Firdapse $47.46Paxlovid $46.11Horizant $44.33Soliris $40.62Nexviazyme $36.00Senza $31.74Qutenza $26.49Ampyra $25.89Keveyis $25.10Agamree $24.07Rytary $23.60Auvelity $23.58Elyxyb - Celecoxib $22.90Spinraza $22.26Aimovig $18.92Infinity $17.90Evusheld $16.30Cala Kiq $16.21Ormalvi $15.66Zembrace Symtouch $14.91Neurostar Tms Therapy System $14.65
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Emmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.